Kiniksa Pharmaceuticals International
KNSA
93.90
+0.36
+0.38%
Kiniksa Pharmaceuticals International
US · KNSA
#1938 by market cap
Listed 2018
93.90
+0.36
+0.38%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
A-
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 5 analysts
Buy
Avg price target 106.20 +13.1%
Price target rangecurrent 93.90
Low98.00
Avg106.20
High122.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-30 | J.P. Morgan | -- | Buy | 122.00 |
| 2026-10-28 | CCORF | -- | Buy | 98.00 |
| 2026-10-28 | Wells Fargo | -- | Buy | 110.00 |
| 2026-10-27 | Goldman Sachs | -- | Buy | 101.00 |
| 2026-10-23 | CCORF | -- | Buy | 98.00 |
| 2026-10-15 | Citi | -- | Buy | 100.00 |
| 2026-09-29 | Wells Fargo | -- | Buy | 87.00 |
| 2026-08-12 | CCORF | -- | Buy | 98.00 |
| 2026-07-30 | Goldman Sachs | -- | Buy | 90.00 |
| 2026-07-29 | CCORF | -- | Buy | 98.00 |
| 2026-07-29 | Citi | -- | Buy | 100.00 |
| 2026-07-29 | J.P. Morgan | -- | Buy | 107.00 |
| 2026-07-28 | TD Cowen | -- | Buy | 95.00 |
| 2026-07-28 | Wedbush | -- | Buy | 99.00 |
| 2026-07-23 | Goldman Sachs | -- | Buy | 75.00 |
| 2026-06-29 | Wedbush | -- | Buy | 72.00 |
| 2026-05-04 | J.P. Morgan | -- | Buy | 72.00 |
| 2026-04-29 | CCORF | -- | Buy | 64.00 |
| 2026-04-29 | Wells Fargo | -- | Buy | 57.00 |
| 2026-04-29 | Wedbush | -- | Buy | 59.00 |
| 2026-04-29 | Citi | -- | Buy | 60.00 |
| 2026-04-28 | TD Cowen | -- | Buy | 65.00 |
| 2026-04-28 | Jefferies | -- | Buy | 71.00 |
| 2026-04-16 | Wedbush | -- | Buy | 58.00 |
| 2026-04-14 | Wells Fargo | -- | Buy | 53.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-10-27 | -- | ±13.35% | +22.23% (beat) |
| 2026/Q2 | 2026-07-28 | -- | ±10.43% | +25.03% (beat) |
| 2026/Q1 | 2026-04-28 | -- | ±14.50% | +23.48% (beat) |
| 2025/Q4 | 2026-02-24 | -- | ±16.08% | -8.21% (in line) |
| 2025/Q3 | 2025-10-28 | -- | ±13.44% | -2.88% (in line) |
| 2025/Q2 | 2025-07-29 | -- | ±13.46% | +12.32% (in line) |
| 2025/Q1 | 2025-04-29 | -- | ±14.08% | +20.54% (beat) |
| 2024/Q4 | 2025-02-25 | -- | ±15.15% | +0.46% (in line) |
| 2024/Q3 | 2024-10-29 | -- | ±15.18% | -15.68% (beat) |
| 2024/Q2 | 2024-07-23 | -- | ±9.98% | +22.91% (beat) |
| 2024/Q1 | 2024-04-23 | -- | ±15.53% | +3.42% (in line) |
| 2023/Q4 | 2024-02-28 | -- | ±16.65% | -2.54% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:29 · For reference only, not investment advice and not tailored to your situation.
Kiniksa Pharmaceuticals International discussion 0 comments